WINDTREE THERAPEUTICS INC /DE/ Quarterly Common Stock, Shares Authorized from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Windtree Therapeutics Inc /De/ quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 120M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 120M 0 0% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 120M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 120M 0 0% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 120M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 120M 0 0% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 120M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 120M 0 0% Dec 31, 2022 10-K 2024-04-16
Q3 2022 120M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 120M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 120M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 120M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 120M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 120M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 120M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 120M 0 0% Dec 31, 2020 10-K 2022-03-31
Q3 2020 120M 0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 120M 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 120M 0 0% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 120M 0 0% Dec 31, 2019 10-K 2021-03-29
Q3 2019 120M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 120M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 120M 0 0% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 120M 0 0% Dec 31, 2018 10-K 2020-04-03
Q3 2018 120M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 120M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 120M +60M +100% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 120M +60M +100% Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 120M +60M +100% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 120M +60M +100% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 60M +24M +66.7% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 60M +24M +66.7% Dec 31, 2016 10-K 2018-04-17
Q3 2016 60M -190M -76% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 60M -190M -76% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 36M -214M -85.6% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 36M -214M -85.6% Dec 31, 2015 10-K 2017-03-31
Q3 2015 250M 0 0% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 250M 0 0% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 250M +100M +66.7% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 250M +100M +66.7% Dec 31, 2014 10-Q 2015-11-05
Q3 2014 250M +100M +66.7% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 250M +100M +66.7% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 150M +50M +50% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 150M +50M +50% Dec 31, 2013 10-K 2015-03-16
Q3 2013 150M +50M +50% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 150M +50M +50% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 100M 0 0% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 100M 0 0% Dec 31, 2012 10-K 2014-03-17
Q3 2012 100M +100M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 100M +100M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 100M +50M +100% Dec 31, 2011 10-K 2013-03-15
Q3 2011 50K* Sep 30, 2011 10-Q 2011-11-14
Q2 2011 50K* Jun 30, 2011 10-Q 2011-08-15
Q4 2010 50M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.